Resolvin E1 Improves Mitochondrial Function in Human Alveolar Epithelial Cells during Severe Inflammation.
Fission
Fusion
Inflammation
Lung
Mitochondria
Resolvin
Journal
Lipids
ISSN: 1558-9307
Titre abrégé: Lipids
Pays: United States
ID NLM: 0060450
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
04
09
2018
revised:
21
12
2018
accepted:
23
12
2018
pubmed:
31
1
2019
medline:
3
9
2019
entrez:
31
1
2019
Statut:
ppublish
Résumé
Severe inflammatory disorders such as sepsis are a major cause of morbidity and mortality worldwide. Mitochondrial dysfunction is regarded as a key feature involved in inflammation pathogenesis. In the present study, we investigated the impact of the omega-3 fatty acid-derived lipid mediator Resolvin E1 (RvE1) on mitochondrial function in experimental pulmonary inflammation. RvE1 was found to exert anti-inflammatory properties in human alveolar epithelial cells during severe inflammation. RvE1 is capable of restoring inflammation-induced mitochondrial dysfunction and the impaired imbalance of mitochondrial fission and fusion. Experimental inhibition of mitochondrial fission with Mdivi-1 in our model is associated with a significantly reduced inflammatory response and improved mitochondrial function. These findings suggest a novel functional mechanism for the beneficial effects of RvE1 in experimental pulmonary inflammatory reactions.
Substances chimiques
Eicosapentaenoic Acid
AAN7QOV9EA
5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid
GND3JH08JA
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
53-65Informations de copyright
© 2019 AOCS.